Lymphocytes are important in early atherosclerosis

Journal of Clinical Investigation

Volumn 108, Issue 2, 2001, Pages 251-259

  Song, Li ^a   Leung, Cynthia ^a   Schindler, Christian ^a,b  

^a Columbia University ^*  (United States)

^b HHSC 1212 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIET; DISEASE COURSE; INFLAMMATORY CELL; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; B-LYMPHOCYTES; DIET; DISEASE MODELS, ANIMAL; FEMALE; HOMEODOMAIN PROTEINS; LISTERIA INFECTIONS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; T-LYMPHOCYTES; TIME FACTORS;

EID: 0034952970     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200111380     Document Type: Article

References (62)

1. Cell-mediated immunity in atherosclerosis
2. Changing concepts of atherogenesis
3. Immunology of atherosclerosis: The promise of mouse models
4. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines
5. Atherosclerosis. The road ahead
6. Signaling and transcription in T helper development
7. Detection of activated T lymphocytes in the human atherosclerotic plaque
8. The IFN gamma receptor: A paradigm for cytokine receptor signaling
9. Molecular bases of the acute coronary syndromes
10. Hypercholesterolemia is associated with a T-helper (TH)1/TH2 switch of the autoimmune response in atherosclerotic apo E-knockout mice
11. Mouse model of atherosclerosis
12. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E
13. Absence of monocyte chemoattractant Protein-1 reduces atherosclerosis in low density lipoprotein receptor deficient mice
14. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
15. Decreased lesion formation in CCR2 -/- mice reveals a role for chemokines in the initiation of atherosclerosis
16. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
17. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice
18. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
19. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice
20. Reduction of atherosclerosis in mice by inhibition of CD40 signaling
21. IFN-γ potentiates atherosclerosis in apoE knockout mice
22. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells
23. Interferon-gamma induces downregulation of Tangier disease gene (ATP- binding-cassette transporter 1) in macrophage-derived foam cells
24. A, B, C...gamma!
25. Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions
26. Donor MHC and adhesion molecules in transplant arteriosclerosis
27. Interferon-γ deficiency prevents coronary atherosclerosis but not myocardial rejection in transplanted mouse hearts
28. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes
29. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E -/- mice
30. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
31. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
32. Trypanosoma cruzi: IL-10, TNF, IFN-γ and IL-12 regulate mice innate and acquired immunity to infection
33. RAG-1-deficient mice have no mature B and T lymphocytes
34. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
35. Quantitative assessment of atherosclerotic lesions in mice
36. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
37. Mild dyslipidemia in mice following targeted inactivation of the Hepatic Lipase gene
38. Specific immunity to Listeria monocytogenes in the absence of IFN-γ
39. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo
40. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells
41. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
42. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100
43. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
44. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice
45. Protective role of interleukin-10 in atherosclerosis
46. Interleukin-10 blocks atherosclerotic events in vitro and in vivo
47. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis
48. IL-10: An "immunologic scalpel" for atherosclerosis?
49. Oxidized phospholipids and isoprostanes in atherosclerosis
50. The oxidation hypothesis of atherosclerosis
51. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
52. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
53. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene
54. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation
55. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-α signals
56. Apolipoprorein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase
57. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα
58. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
59. Genetic defects in lipoprotein metabolism: Elevation of atherogenic lipoproteins caused by impaired catabolism
60. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition
61. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology